We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

13 hedge funds and large institutions have $4.87M invested in Genetic Technologies Ltd. in 2015 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,928% more capital invested

Capital invested by funds: $161K → $4.87M (+$4.71M)

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

160% more funds holding

Funds holding: 5 → 13 (+8)

Holders
13
Holders Change
+8
Holders Change %
+160%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
–
Closed
2
Calls
$70K
Puts
–
Net Calls
+$70K
Net Calls Change
+$70K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$2.42M
2
WAM
Wolverine Asset Management
Illinois
+$544K
3
Millennium Management
Millennium Management
New York
+$223K
4
Citadel Advisors
Citadel Advisors
Florida
+$167K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$61.3K

Top Sellers

Rank Fund Capital Flow
1
TDC
Thompson Davis & Co
Virginia
-$27K
2
Ameriprise
Ameriprise
Minnesota
-$9K

GENE Hedge Fund Activity: Q1 2015 in Review

13 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2015, worth a combined $4.87M — up 2,928% from $161K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GENE positions and 2 closed out — a net gain of 9 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.42M. The largest seller was Thompson Davis & Co, exiting entirely with an estimated $27K sold.

  • 13 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2015, up from 5 in Q4 2014.
  • Funds reported $4.87M of Genetic Technologies Ltd. stock for Q1 2015, up 2,928% quarter-over-quarter.
  • 11 funds opened new Genetic Technologies Ltd. positions in Q1 2015 and 2 closed out, a net change of +9 holders.
  • The largest Genetic Technologies Ltd. buyer in Q1 2015 was Renaissance Technologies, an estimated $2.42M added.
  • The largest Genetic Technologies Ltd. seller in Q1 2015 was Thompson Davis & Co, an estimated $27K sold.

Based on aggregated 13F filings for Q1 2015.